Trial Profile
A Phase 1, Open-Label, Study of the Effect of Cimetidine, a Known Inhibitor of Active Renal Secretion, on the Single-Dose Pharmacokinetics of Intravenously-Administered Methylnaltrexone in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary) ; Cimetidine
- Indications Constipation; Pancreatic cancer
- Focus Pharmacokinetics
- Sponsors Progenics Pharmaceuticals; Salix Pharmaceuticals
- 21 Jul 2011 New trial record